Register for Upcoming Webinar on Leukemia and Lymphoma
February 05, 2014 |
On Thursday, February 20th, at 2:00 p.m. EST, assistant professor at Standford Cancer Institute Holbrook E. Kohrt, M.D., Ph.D., will share with us his current investigations in novel therapeutic strategies to enhance anti-tumor immunity, specifically in patients with leukemia and lymphoma. This 45-minute webinar, which is part of the Cancer Research Institute's Breakthrough in Cancer Immunotherapy webinar series, is free to the public, but seats are limited, so register now.
Holbrook Kohrt, M.D., Ph.D.
"Immunologic Strategies for Leukemia and Lymphoma"
February 20, 2014, at 2:00 p.m. EST
Dr. Kohrt attended Stanford University Medical School as the Baxter Foundation Scholar, Howard Hughes Scholar, and American Society of Hematology Research Fellow. During this time, he developed, validated, and nationally implemented a nomogram for risk prediction in early stage breast cancer. He trained in Internal Medicine at Stanford through the Clinical Investigator Pathway and completed fellowship in Hematology and Oncology at Stanford with a research focus on preclinical models of novel immunomodulatory antibodies.